ANI Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.8% | -4.1% | +22.2% | +7.6% | -1.8% | -1.7% | +1.7% | +7.3% | +12.7% | -7.4% | +2.8% | -5.6% | -6.6% | +3.8% | -2.6% | +9.3% | +8.1% | -4.8% | -10.8% | +7.1% | +17.0% | +5.8% | +14.5% | +13.5% | +12.4% | +13.3% | +9.1% | +13.1% | -0.1% | +4.4% | +0.4% | +7.5% | +28.5% | +3.4% | +7.2% | +7.8% | +8.4% | -3.9% | +12.0% | – | |
| – | +1.4% | -3.1% | +28.9% | -0.2% | -3.0% | +1.2% | -19.8% | -6.0% | +29.0% | -26.9% | +6.2% | -4.0% | +18.6% | +22.5% | -5.1% | -2.8% | +22.0% | -18.6% | +11.7% | +9.4% | +38.9% | +1.1% | +3.0% | -6.8% | +10.4% | +3.8% | +12.1% | +13.8% | +11.1% | -8.0% | +17.4% | +9.3% | +27.3% | -9.0% | +2.2% | +55.5% | -91.8% | +1,105.3% | -12.5% | – | |
| – | -2.5% | -5.0% | +16.8% | +14.6% | -0.9% | -3.9% | +18.9% | +14.4% | +5.4% | +3.2% | +1.5% | -6.2% | -17.0% | -7.3% | -0.7% | +18.3% | -0.5% | +5.6% | -23.8% | +5.1% | -2.2% | +11.7% | +27.7% | +32.1% | +13.7% | +19.3% | +7.5% | +12.7% | -6.6% | +12.8% | -9.0% | +6.1% | +29.4% | +12.5% | +10.2% | -18.3% | +112.5% | -48.2% | +34.9% | – | |
| – | -87.0% | +1,098.5% | +33.9% | +21.6% | +0.6% | -20.7% | +144.4% | -9.1% | -25.4% | +25.6% | +32.0% | -13.7% | -6.1% | +35.6% | -52.2% | -3.2% | +25.3% | -19.4% | -5.5% | -12.4% | +27.9% | +68.0% | -21.0% | +83.8% | -31.8% | +13.4% | +24.5% | +50.8% | -11.3% | +6.5% | -30.6% | +38.8% | +64.4% | -36.5% | +56.5% | -25.6% | -0.3% | -13.5% | +39.1% | – | |
| – | +195.3% | -64.4% | +1.2% | +8.7% | +182.9% | -60.5% | +11.2% | +18.1% | +160.7% | -56.7% | +6.8% | +1.2% | +191.3% | -67.3% | +55.0% | -25.9% | -13.0% | +5.0% | +31.0% | -8.7% | +78.7% | -3.7% | +8.1% | +1.9% | +6.9% | +7.5% | +3.6% | +8.4% | +5.8% | +8.0% | +10.0% | +49.7% | -11.8% | +9.8% | +6.9% | -6.3% | -0.2% | -3.8% | +24.4% | – | |
| – | -4.4% | +17.3% | +6.6% | +6.6% | +4.5% | +3.7% | +21.6% | +6.7% | +2.2% | +32.2% | -12.8% | -1.4% | +20.1% | +2.8% | +9.1% | -23.1% | +7.7% | -2.7% | +32.9% | -25.4% | +62.6% | -2.7% | +4.2% | +8.6% | +0.3% | +5.5% | +4.5% | +6.3% | +8.7% | -5.0% | +10.6% | +40.7% | +8.4% | -14.6% | +25.5% | -27.6% | +112.9% | -55.5% | +48.9% | – | |
| – | -83.6% | +256.3% | +51.2% | +33.4% | -20.9% | -11.4% | +11.1% | +39.3% | +13.2% | -61.5% | +111.1% | -21.1% | -163.7% | – | – | – | -88.2% | +819.9% | -610.8% | – | – | – | – | – | – | +443.7% | +25.3% | +44.7% | -62.5% | +202.0% | -74.6% | -497.0% | – | – | -47.0% | +64.4% | +111.0% | -19.7% | +4.5% | – | |
| – | +0.1% | +2.6% | +3.2% | +0.9% | -0.9% | +20.1% | +2.6% | +1.0% | -3.8% | -7.5% | +1.6% | -2.1% | -14.0% | -29.2% | +15.9% | +6.5% | +1.8% | -3.9% | +3.1% | -1.3% | +77.8% | +48.9% | +0.8% | +8.9% | +3.3% | +2.5% | -7.7% | -9.9% | -10.2% | -19.9% | +1.2% | -49.9% | +158.0% | +34.8% | +1.4% | -42.5% | +383.2% | -83.5% | -3.5% | – | |
| – | -131.8% | – | +135.8% | +61.4% | -31.8% | -34.7% | +23.3% | +81.7% | +15.3% | -87.5% | +546.2% | -33.3% | -293.3% | – | – | – | -3,881.0% | – | -23,982.9% | – | – | – | – | – | – | – | +142.4% | +119.3% | -91.8% | +2,575.3% | -109.0% | – | – | – | -47.3% | +221.1% | -6.9% | +27.8% | -7.8% | – | |
| – | -121.0% | – | +142.6% | +30.3% | +745.2% | -95.8% | +22.6% | +83.1% | +43.7% | -75.4% | -239.2% | – | -4,501.6% | – | – | – | – | -100.8% | – | – | – | – | – | – | – | – | -237.2% | – | -113.2% | – | – | – | – | – | -54.1% | +263.5% | -44.5% | +169.0% | +15.4% | – | |
| – | -142.8% | – | +133.2% | +76.1% | -305.5% | – | +22.9% | +81.4% | +7.8% | -91.8% | +1,372.3% | -40.8% | -226.2% | – | – | – | -937.6% | – | -16,502.3% | – | – | – | – | – | – | – | +334.0% | +59.2% | -88.4% | +1,476.4% | -112.6% | – | – | – | -45.5% | +182.3% | +13.9% | +7.3% | -16.2% | – | |
| – | -49.0% | +60.1% | +24.4% | +17.4% | -12.9% | +1.9% | +6.0% | +20.2% | +5.2% | +3.7% | -7.7% | -10.7% | -71.5% | -29.9% | -106.7% | – | -20.5% | +21.3% | -132.0% | – | -289.6% | – | – | +413.2% | +67.0% | +41.6% | +10.1% | +22.5% | -33.9% | +103.9% | -61.8% | -178.6% | – | +225.6% | -18.9% | +55.8% | +25.8% | -25.4% | +5.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.